mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.3 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
0.052 |
0.3 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |